Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during Flow-Dependent vascular remodeling

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yu, Jun ^a   Zhang, Yuanyuan ^a   Zhang, Xinbo ^a   Rudic, R Daniel ^a,c   Bauer, Philip M ^a,d   Altieri, Dario C ^b   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; SURVIVIN; BIRC5 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; NITRIC OXIDE; NOS3 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR A; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD FLOW; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MECHANOTRANSDUCTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANGIOGENESIS; ANIMAL; BLOOD VESSEL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

MUS;

ANIMALS; APOPTOSIS; BLOOD VESSELS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; IMMUNOENZYME TECHNIQUES; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84857077747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031495     Document Type: Article

References (31)

1. Davies PF, (1995) Flow-mediated Endothelial Mechanotransduction. Physiol Rev 75: 519-560.
2. Gibbons GH, Dzau VJ, (1996) Molecular therapies for vascular diseases. Science 272: 689-693.
3. Kamiya A, Togawa T, (1980) Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 239: H14-H21.
4. Langille BL, O'Donnell F, (1986) Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407.
5. Langille BL, Bendeck MP, Keeley FW, (1989) Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am J Physiol pp. H931-H939.
6. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, et al. (1998) Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736.
7. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, et al. (1998) Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101: 1225-1232.
8. Dai X, Faber JE, Endothelial Nitric Oxide Synthase Deficiency Causes Collateral Vessel Rarefaction and Impairs Activation of a Cell Cycle Gene Network During Arteriogenesis. Circ Res.
9. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, et al. (2005) Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 102: 10999-11004.
10. Rudic RD, Sessa WC, (1999) Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 64: 673-677.
11. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC, et al. (2002) Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8: 987-994.
12. Yamasaki Y, Miyoshi K, Oda N, Watanabe M, Miyake H, et al. (2001) Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res 88: 630-636.
13. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, et al. (2000) Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 97: 13103-13107.
14. Grossman D, Kim PJ, Schechner JS, Altieri DC, (2001) Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A 98: 635-640.
15. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, et al. (2004) A new role for Nogo as a regulator of vascular remodeling. Nat Med 10: 382-388.
16. Korshunov VA, Berk BC, (2003) Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 23: 2185-2191.
17. Mondy JS, Lindner V, Miyashiro JK, Berk BC, Dean RH, et al. (1997) Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ Res 81: 320-327.
18. Sharma RV, Tan E, Fang S, Gurjar MV, Bhalla RC, (1999) NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells. Am J Physiol 276: H1450-1459.
19. Gurjar MV, Sharma RV, Bhalla RC, (1999) eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 19: 2871-2877.
20. Sandirasegarane L, Charles R, Bourbon N, Kester M, (2000) NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest. Am J Physiol Cell Physiol 279: C225-235.
21. Jacob A, Molkentin JD, Smolenski A, Lohmann SM, Begum N, (2002) Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs. Am J Physiol Cell Physiol 283: C704-713.
22. Ohashi H, Takagi H, Oh H, Suzuma K, Suzuma I, et al. (2004) Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res 94: 785-793.
23. Ambrosini G, Adida C, Altieri DC, (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
24. Altieri DC, Marchisio PC, Marchisio C, (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327-1333.
25. Altieri DC, (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46-54.
26. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, et al. (1999) Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781-788.
27. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, et al. (2000) Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156: 393-398.
28. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, et al. (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275: 9102-9105.
29. Chao JI, Kuo PC, Hsu TS, (2004) Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem 279: 20267-20276.
30. Rudic RD, Bucci M, Fulton D, Segal SS, Sessa WC, (2000) Temporal events underlying arterial remodeling after chronic flow reduction in mice: correlation of structural changes with a deficit in basal nitric oxide synthesis. Circ Res 86: 1160-1166.
31. Kritz AB, Yu J, Wright PL, Wan S, George SJ, et al. (2008) In vivo modulation of Nogo-B attenuates neointima formation. Mol Ther 16: 1798-1804.